Immunitybio. Every tracked FinTwit mention of $IBRX, newest first. 242 mentions since the first on Aug 31, 2025. See the price chart.
June 2026 · 4 mentions
Jun 4
mon — The best stocks to buy on a red day are the ones you already believe in for the long term.
For me, those are the companies I've spent the most time researching.
Those are: $IREN…↗
Jun 3
Adam Feuerstein ✡️ — We talk about cult stocks a lot. What is? What isn't? What it means.
People, let me tell you about a cult stock... $IBRX.
Exhibit A-Z, 0 - 10,000. No further proof necessary. h…↗
Jun 3
mon — My favourite stocks in each sector right now:
Nuclear: $SMR
Robotics: $OUST
Rare Earth: $UAMY
Copper: $COPX ETF
Memory: $DRAM ETF
Space: $SATL & $VELO
Solar: $CSIQ, $TE &…↗
Jun 2
mon — If I were forced to build something more diversified without losing the same asymmetric mindset, my long-term portfolio would probably look like this:
- $IREN
- $HIMS
- $ASTS
- $O…↗
May 2026 · 15 mentions
May 29
Jacob Plieth — @adamfeuerstein You reckon the Anktivians are aware of a world beyond $IBRX?↗
May 29
Adam Feuerstein ✡️ — The $IBRX hysteria boost on this site in recent days/weeks is a solid indicator of panic. The Anktiva “story” and its related components are falling apart.↗
May 25
mon — My favourite stocks/ETF by sector:
- Nuclear: $SMR
- Robotics: $OUST
- Rare Earth: $UAMY
- Copper ETF: $COPX
- Memory ETF: $DRAM
- Health: $HIMS & $IBRX
- AI Infrastructure: $I…↗
May 21
Dustin — $IBRX Looking forward to ASCO tomorrow evening
It's Actually Early were going to have to put up with the Corruption Till we Don't, But Hug Strides are being Built with all This Po…
April 2026 · 43 mentions
Apr 30
Jason Luongo — 7. $IBRX - $6.99
ImmunityBio. Cancer immunotherapy focused on bladder cancer treatment. FDA-approved Anktiva is the first IL-15 superagonist to reach market. Pipeline expanding in…↗
Apr 30
Dustin — $IBRX H.C. Wainwright Sticks to Its Buy Rating for ImmunityBio (IBRX)
In a report released today, Andres Y. Maldonado from H.C. Wainwright maintained a Buy rating on ImmunityBio,…↗
Apr 30
Dustin — $IBRX new 10 patient trial posted today for 2 locations i South Africa https://t.co/Dx709Ig9S7↗
Apr 29
Dustin — $IBRX Nearly 60% Daily Short Volume once again.
If Short HF’s thought IBRX would correct on Bearish sentiment, they wouldn’t need the Price Manipulation and Naked Shorting. The…
March 2026 · 72 mentions
Mar 31
Dustin — $IBRX "Capital in place. never give up…"
I'm not the best but I literally called the deal before it happened. Just saying. https://t.co/vbqWK7Imi2↗
Mar 31
Dustin — $IBRX 08:37 on Mar. 31 2026
ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global…↗
Mar 31
Dustin — $IBRX My guess is Saudis had agreed to buy a big chunk and it was at higher price prior to the war and they waited for ink to dry. Then war happened and the delay in announcin…↗
Mar 31
Dustin — $IBRX strengthening a balance sheet usually means a wack of cash!🤔
Imagine if the US Govt or Saudis make an investment in IBRX. Where would the price go???
February 2026 · 55 mentions
Feb 28
Dustin — $IBRX My issues with the show:
1) the stupid chick sitting next to Dr Pat.
2) the show wasn’t long enough. Should have been 90-120min.
3) the patients didn’t have enough time…↗
Feb 28
Dustin — $IBRX I was watching Chris Cuomo tonight when a panelist tried to pivot the discussion toward general cancer and immunity. Our hero Dr. PSS wasn’t having it—he outsmarted her immed…↗
Feb 28
Dustin — $IBRX
PSS laughing at Old FDA, lying a
😂 https://t.co/7zxwwE6G8X↗
Feb 27
KaizenInvestor — Weekend is a great time to do some research.
Companies I’m going to look into this weekend:
$IBRX
$AAOI
$UAMY
$LITE
$POET
$TE
$AMPX
Here is my method 👇
January 2026 · 40 mentions
Jan 30
Adam Feuerstein ✡️ — @bullishbruk I didnt post publish a story on $IBRX today.↗
Jan 30
Dustin — $IBRX
The Stand Up to Cancer (SU2C) Glioblastoma Innovation Scientific Summit takes place on January 31, 2026, in Pasadena, California, featuring key updates on immunotherapy, in…↗
Jan 30
Dustin — $IBRX Something worth discussing/exploring here is how the relationships with these various Checkpoint Inhibitor companies will work. Do they need IBRX's permission to use Anktiva?…↗
Jan 30
Dustin — $IBRX institution continuative accumulation...now over 161 million shares!!!!🧨
Smart money positioning is worth paying attention to.
They probably know something that I don't.
f…
November 2025 · 2 mentions
Nov 9
Adam Feuerstein ✡️ — @StephenWangs73 @drpatrick So, $IBRX is giving away Anktiva for free? I’ll have to ask about that. Odd business strategy. How do you think the company is going to win approval for…↗
Nov 8
Adam Feuerstein ✡️ — @SweetStocks22 @drpatrick $IBRX is more than welcome to submit data to the FDA to seek an expanded approval for Anktiva / Bioshield beyond its limited approval for bladder cancer.…↗
October 2025 · 1 mention
Oct 25
Adam Feuerstein ✡️ — For @alc2022 and all the other folks naively buying into the exaggerated medical claims that @drpatrick is making about $IBRX Anktiva
Piercing the hype around Dr. Patrick Soon-Shi…↗
September 2025 · 9 mentions
Sep 11
Adam Feuerstein ✡️ — @JBluePolaski_ Quilt 2.005 could potentially expand use of Anktiva in bladder cancer. The FDA rebuffed $IBRX earlier attempt when it issued the refuse-to-file letter. Will the com…↗
Sep 11
Adam Feuerstein ✡️ — @MAugusterfer Thank you. Anktiva is an approved drug, so doctors can prescribe it off label if they believe it will help their patients with other types of cancer. $IBRX and @drpa…↗
Sep 11
Adam Feuerstein ✡️ — @JBluePolaski_ The burden for $IBRX is to prove Anktiva improves outcomes for cancer patients — hopefully by prolonging survival. It is not enough to show the drug improves or prev…↗
Adam Feuerstein ✡️ — $IBRX -- The FDA accepted the sBLA to expand Anktiva to include the treatment of MNBIC papillary. The PDUFA date is Jan. 6, 2027. Standard review.
A positive development for Im…↗
May 19
Adam Feuerstein ✡️ — A lot of words but no clarity on whether the FDA accepted $IBRX sBLA for Anktiva in NMIBC papillary disease.
PDUFA date?
Also, if cis and papillary are the same disease, then a…↗
May 19
Dustin — $IBRX After listening to the FDA workshop, my impression is that the FDA is likely to move fast on the BLA application for BCG Tokyo.
I have the impression that FDA will move fas…↗
May 18
Adam Feuerstein ✡️ — The truth: $IBRX and @DrPatrick paid for an hour of podium time in the exhibition hall of #AUA26. It was an infomercial, not a presentation included in the meeting’s official scien…↗
May 18
Dustin — $IBRX The Japan deal could help ease the FDA’s requirement for companies to prove large-scale production capability before approval. It may be the final move to alleviate the agon…↗
May 11
Dustin — $IBRX "Global expansion happening!"
Good job! Dr. PSS!!!↗
May 10
Adam Feuerstein ✡️ — The cult of $IBRX, purpose built by @DrPatrick through social media and podcasts. His followers aren’t getting a cancer cure, but they have boosted his paper wealth by billions.↗
May 8
Dustin — $IBRX New Prostate Trial listed today ! https://t.co/ybaoRcJdiW↗
May 7
mon — > Hanta Virus
> Iran has rejected the US peace deal
What a disaster.
$HIMS -5%
$NUAI -6%
$IREN -7%
$SATL -8%
$BE -9%
$IBRX -10%
$VELO -11%
$UAMY -12%
$MRLN -13%
$AAOI -14%…↗
May 6
Adam Feuerstein ✡️ — @janiesaysyay @bullishbruk @ImmunityBio @LoriMills4CA42 @alc2022 @MartyMakary @DrMakaryFDA I'm very sorry about your mom getting lung cancer, but her Covid booster didn't cause it.…↗
May 6
Dustin — $IBRX Per updated 13f from Fintel, insitutions accumulated 1.4 million more shares as of today shrinking the retail float - worth an update to the graphic (5/5/26)
Look at Davidso…↗
Dustin — $IBRX In fact, we’ve seen additional positive milestones since the earnings report. Last week’s action looks more like technical balancing and MM hedging. A weekly golden cross is…↗
Apr 28
Dustin — $IBRX
1. What exactly happened on March 9
IBRX resubmitted its sBLA for ANKTIVA + BCG in BCG‑unresponsive papillary‑only NMIBC, and FDA formally acknowledged receipt of that resu…↗
Apr 27
Dustin — $IBRX Traders have previously expressed optimism that U.S. President Donald Trump could again support international momentum for anktiva, after the founder said earlier that discu…↗
Apr 24
Adam Feuerstein ✡️ — But if I do what this person asks, I would be lying to myself, misleading others and prove myself to be a propagandist rather than someone who tries to be a fair arbiter even when…↗
Apr 24
Dustin — $IBRX short interest 3/31/2026: 135MM shares, 36% of float, ~ 5d to cover
Also IBRX Still 51.5% Daily Short Volume. They’re not giving up! https://t.co/Pgvbvh2sJ5↗
Apr 21
mon — What a day.
- $VELO smashed it. 🤯 +31%.
- $OUST & $SATL had a great day.
- $IBRX Now Available in Saudi Arabia.
- for Bladder and Lung Cancer Patients.
- no idea why it's down. Th…↗
Apr 20
Adam Feuerstein ✡️ — @pdsandiego @LoriMills4CA42 @DrPatrick Merck received SOME of its initial Keytruda approvals by conducting single arm studies in patients with advanced cancers refractory to all cu…↗
Apr 20
Adam Feuerstein ✡️ — For the umpteenth time, these posters have zero relevance to Anktiva unless, or until, $IBRX conducts/completes randomized clinical trials that demonstrate the drug improves outcom…↗
mon — This is a portfolio built with very small capital.
It is spread across 6+ broad sectors:
· Space/Defense: $RKLB, $ASTS, $OSS, $ONDS
· Fintech/Insurance: $SOFI, $OSCR
· AI infrastr…↗
Apr 18
mon — My current portfolio:
$IREN - Currently over 50% of my portfolio.
$HIMS - Incredible week +48%. Peptides new AI.
$ONDS - Reduced greatly, but will revisit later.
$KRKNF - Recently…↗
Dustin — $IBRX posts from Yahoo board from the current AACR meeting https://t.co/bEAxC8rzti↗
Apr 17
Jason Luongo — Growth stocks I'm watching right now:
$IREN | $48.18 - AI data center infrastructure, 4.5 GW pipeline, largest single-site build in the US
$CRDO | $164.09 - AI connectivity, 1.6T…↗
Apr 17
mon — Everyone’s goal is to own companies before they’re obvious.
That’s a different way of investing.
When your portfolio is small, it’s easier to do this. You can buy names that nobo…↗
Apr 17
Dustin — $IBRX Today’s move was entirely based on 60%+ Short Volume, and off-exchange shenanigans.
Held their powder until the biotech funds were gonna be red to not fight with their manip…↗
Apr 15
Adam Feuerstein ✡️ — FDA saying, this is exactly why we issued the warning letter to $IBRX.↗
Apr 14
Jason Luongo — Every industry has an incumbent that stopped innovating.
These companies are coming for their lunch:
$HOOD - brokerage
$SOFI - banking
$OSCR - health insurance
$PLTR - enterprise…↗
Apr 14
Dustin — $IBRX new Anktiva trial listed yesterday.
Sounds like the current trial data on hand points to 1st line therapy being a reachable goal. https://t.co/NXMK1B4isZ↗
Apr 14
Adam Feuerstein ✡️ — Truly nothing better or more hilarious than Sean Spicer posting false and misleading claims about $IBRX Anktiva while promoting a grifter miracle powder supplement at the same time…↗
Apr 13
Adam Feuerstein ✡️ — Today's $RVMD study outcome in pancreatic cancer is a good lesson for all the $IBRX @DrPatrick fans.
Stop with all the hand-waving "cancer cure" podcasting social media nonsense.…↗
Apr 13
Dustin — $IBRX ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum.
“We recently compiled a list of the 10 Best Mid Cap Stocks to Invest In According to Billiona…↗
Apr 12
InvestmentGuru — 10 Stocks That Have Nearly DOUBLED in 2026 YTD. While the market bleeds, these names are printing
$SNDK
Pure-play NAND flash powerhouse spun off from Western Digital. Revenue up…↗
Apr 10
Dustin — $IBRX “Amazingly advanced in immune cell therapy development”
A billionaire in his 70s working tirelessly to save lives and raise awareness about ALS and cancer.
He's taking on…↗
Apr 9
Dustin — $IBRX It looks like warrants of $180M have been fully exercised and $75M in non-diluted funding will be added to Q2 cash balance. Q2 revs gonna be much higher than $44M bc it will…↗
Apr 8
Jason Luongo — I just closed 6 cash-secured put trades for an average annualized return of 144%. Average trade length: 16 days.
The puts were sold on: $SOFI $IBRX $HOOD $ZETA $BMNR $XSP/ $SPX
H…↗
Apr 8
mon — Global oil prices have fallen sharply and stock markets have jumped after the US and Iran agreed to a conditional two-week ceasefire deal that includes the reopening of the key Str…↗
Apr 8
Dustin — $IBRX I’ve been in this name for years and I’m not a mindless pumper. We have multiple real catalysts ahead (regulatory milestones, label expansions for Anktiva, potential recombin…↗
Apr 7
Jason Luongo — I'm only going to say this once.
These 12 stocks have the potential to create millionaires by 2028:
$NVDA at $175 → Avg PT $266 (+52%)
$AMZN at $212 → Avg PT $281 (+33%)
$IREN at…↗
Apr 7
Dustin — $IBRX Hilarious to see daily short volume is averaging between 45 and 50%, this is why the stock is entirely dependent upon news or PSS tweeting to overcome that shorting volume. O…↗
Apr 6
Dustin — $IBRX addressed FDA ad concerns, removed a podcast, and clarified ANKTIVA info while tightening rules on future promotions. https://t.co/GvoTLe7QeE↗
Apr 6
Dustin — $IBRX If you aren't watching the Dunkirk and NANT Leonardo developments, you aren't seeing the real valuation.
The NANT Leonardo AI-Robot Revolution is Automated Cellular Ma…↗
Apr 3
Dustin — $IBRX Total shares control by Dr. PATRICK not including his convertable loan. Approximately-653,611,736 shares or about 63% of the float. Then add Institutions, then add retail..y…↗
Apr 3
Dustin — $IBRX ImmunityBio Insider Makes Bold Multi-Million Dollar Bet on the Company's Future. https://t.co/vNmOoM7uOW↗
Apr 2
mon — 🚨: Iran Is Drafting a Protocol With Oman to Oversee Strait of Hormuz - Bloomberg.
Market: 🟢
$IREN +1.38%
$SATL +17.86%
$VELO +5.93%
$IBRX +1.54%
$KRKNF +1.68%
$ONDS +4.77%
$OUS…↗
Apr 2
Jason Luongo — 2. $IBRX at $7.13 - Biotech/Immunotherapy
ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer. Full-year 2025 revenue hit $113M, up 700% YoY. Q4…↗
Apr 2
Dustin — $IBRX Another well educated opinion and supporter
Elaine Chin, MD - Future Of Cancer Care
There are certain times in life when you have to stand up for something you know is righ…↗
Apr 1
Dustin — $IBRX The financing was a very big and calculated move,
I dug into it after the close, and this sets the company up for a potential to be profitable by end of 2026 - early 2027…↗
Apr 1
Dustin — $IBRX 👀 I like acquiring productive real estate for $1
I herd a Guy Named Hot Air Marty Makary has a House that might be coming up for sale real Cheap , He's Probably going to ha…↗
Dustin — $IBRX IBRX Stock Eyes Breakout Quarter: Anktiva Enters Phase 2 Long COVID Trial As Europe Expansion Plans Emerge
Founder Patrick Soon-Shiong said he was invited by a European heal…↗
Mar 30
Dustin — $IBRX last week before the FDA Warning there was a surge of 1700% on “Put” options.
This week there is a 700% increase and 1200% increase on “Call” options betting on 25% profits…↗
Mar 27
Dustin — $IBRX
P2 Critically Ill Pneumonia Trials (with or without Sepsis), Completion Nov 2026.
•Larger TAM than Cancer
•A thesis test for Lymphopenia
•Unmet need- high mortality
•L…↗
Mar 27
Dustin — $IBRX Amazing long-term study published this morning. Stock should be at $50.00 now！
All (6 out of 6, 100%) demonstrated a prolonged duration of complete remission with a median…↗
Mar 26
Jason Luongo — These 10 stocks have the potential to create millionaires by 2028:
$NVDA - AI Compute
$AMZN - Cloud/E-Commerce
$IREN - AI Infrastructure
$HOOD - Fintech
$ZETA - AI Marketing
$ONDS…↗
Mar 26
Jacob Plieth — And the bullshit press releases from $IBRX mount up! What's it going to be tomorrow? Pat confirms he's had a nice breakfast and is ready for the day?↗
Mar 26
Dustin — $IBRX If you held thru yesterdays bullshit then you can hold thru anything
Had a great day today despite the garbo financial media slop "Why is IBRX down" and "a lawyer near you c…↗
Mar 26
Dustin — $IBRX Definitely PR worthy. A quick PR summarizing P1 results, and announcing P2 Trial would have made sense. Regardless, very significant Trial. Will confirm Lymphopenia thes…↗
Mar 26
Dustin — $IBRX free ass publicity?!! https://t.co/rdCknRyqd9↗
Mar 25
Adam Feuerstein ✡️ — @DrPatrick Hey @DrPatrick - I was told by one of the QUILT 2.005 investigators that $IBRX restricted enrollment to BCG-naive NMIBC + CIS, a more narrow disease indication than you…↗
Mar 25
Dustin — $IBRX 2 new Anktiva/INKT Cell combo trials listed👇
You can follow me, I'll be tracking $IBRX all the way 🫶 https://t.co/9G5gjeiBe4↗
Mar 25
Dustin — $IBRX Vinay Prasad from the FDA is leaving!
maybe this was his last revenge.
Vinay Prasad, the Trump administration regulator who angered pharma companies and crushed the hopes o…↗
Mar 25
Dustin — $IBRX Retail shorts are not the problem here, they are not powerful enough to manipulate this stock. This is a coordinated work of Institutions, Insurances, and the so called big p…↗
Mar 25
Dustin — $IBRX The FDA needs to be completely re-tooled. It has become an impediment to health and well being discoveries. That such an effective therapy has been held back in America whi…↗
Mar 24
Adam Feuerstein ✡️ — FDA slams Soon-Shiong @DrPatrick and ImmunityBio $IBRX for making ‘false and misleading’ claims about a drug https://t.co/MNcmA49i33 via @pharmalot↗
Mar 24
Dustin — $IBRX Any wonder why the FDA even exists. It is nothing but a Political Organization that is funded by Big Pharma. Robert Kennedy needs to clean house here. The NCCN agreed with th…↗
Mar 24
Jason Luongo — My Q2 2026 watchlist:
$AMZN - AWS powering OpenAI + Anthropic. $200B capex this year. AI infrastructure backbone.
$IREN - $9.7B Microsoft contract ramping. 150K GPUs deploying. C…↗
Mar 24
mon — So FDA issued a warning letter to $IBRX CEO Richard Adcock over misleading promotional materials for ANKTIV.
Stock currently down 20.01%.
This is a great opportunity for long-ter…↗
Mar 24
Adam Feuerstein ✡️ — Recall, I wrote previously about how $IBRX and @DrPatrick misrepresented results from Anktiva's bladder cancer trials and his interactions with FDA officials. Today's warning lette…↗
Mar 24
Adam Feuerstein ✡️ — FDA issued a warning letter to $IBRX about "false and misleading" statements regarding Anktiva made by @DrPatrick on the Sean Spicer TV show.
https://t.co/X9FEBPsDQA
h/t @AlecGa…↗
Mar 24
Dustin — $IBRX “The first AI machine driven, cell therapy robotic manufacturing system landing soon!”↗
Mar 24
Dustin — $IBRX new Phase 1 Pancreatic TRial listed with Anktiva https://t.co/jpa3bOevJ5↗
Mar 24
Dustin — $IBRX look what happened today.
Short HF’s had a change of sentiment.
Record Low Short Volume Today! https://t.co/EdPNGXRIzO↗
Mar 23
Wayne Liang — Anticipating a third BD on $IBRX soon. https://t.co/zj7In4SKNf↗
Dustin — $IBRX NCCN Adds ImmunityBio’s Anktiva to Bladder Cancer Guidelines https://t.co/PslJKm7WjX↗
Mar 23
Dustin — $IBRX 🚨ImmunityBio call volume above normal and directionally bullish https://t.co/FRRwT41sYA↗
Mar 23
Dustin — $IBRX Shorts are burning. https://t.co/T8IwjjgfH7↗
Mar 23
Wayne Liang — Interesting... $IBRX https://t.co/IRRNg7hBb2↗
Mar 23
Dustin — $IBRX 38 Annual Roth 2026 conferences March 22-24 I wonder what they’re going to talk about. https://t.co/qNZ2TTj2gt↗
Mar 22
Dustin — $IBRX ImmunityBio Gains First Asian ANKTIVA Nod As Cell Therapy Story Builds https://t.co/OU7FjirK5l↗
Mar 20
Dustin — $IBRX Trump is backing up immunity biotech?!↗
Mar 20
Dustin — $IBRX Whilst consolidation could persist for a few days, the market is in a down trend, portfolios are in question, then rebound.
Also Anktiva has been officially listed by the…↗
Mar 20
Dustin — $IBRX CEORichard Adcock speaking at the annual Roth Capital conference on Tuesday. https://t.co/kRFueXx6Rl↗
Mar 19
Jason Luongo — I'm 34 years old and a self-made millionaire. My March advice:
$NVDA (NVIDIA) - Strong Buy
$AMZN (Amazon) - Strong Buy
$IREN (IREN Limited) - Buy
$HOOD (Robinhood) - Strong Buy
$Z…↗
Mar 19
Dustin — $IBRX This is how the system gets stacked against small biotech by Big Pharma
1. Get corrupt journalists and media voices on the payroll to publish malicious content against small…↗
Mar 18
Dustin — $IBRX ImmunityBio's Anktiva Could See More Upside https://t.co/V4NTyxWfDa↗
Mar 18
Dustin — $IBRX A sizable buy to IBRX for the Saudi deal could take out this game going on with the shorts. And some help from the US would make it even better. Something in the works? Would…↗
Mar 17
Dustin — $IBRX with Saudis and EU on board valuation is a joke. Enough said.↗
Mar 17
Dustin — $IBRX Time to sit back and enjoy the show.
tomorrow should be fun!
Also,for anyone who doesn’t realize how big it is when Anktiva shows up in the NCCN guidelines: it’s there beca…↗
Mar 16
Dustin — $IBRX No. doubt!
You should look at the forest, not the trees.
GL. https://t.co/IuDOWWsgRL↗
Mar 16
Dustin — $IBRX So is there a major announcement tomorrow? The money delivered to IBRX will hopefully be more than just the cost of the cells. Immunity Bio has put out a lot to get this goin…↗
Mar 13
Dustin — $IBRX In the past 6mos IBRX has risen almost $6. PSS is perhaps the best I've seen with accurate and positive company updates. Patrick Soon-Shiong has a fabulous team.
The databa…↗
Mar 13
Dustin — $IBRX The dip to $7.82 felt brutal, but it had a clear technical purpose: testing the ultimate institutional floor. We closed just below the 200-day SMA, which is exactly the buy z…↗
Mar 12
Dustin — $IBRX Hard to forget with all the recent job postings and the good Doctor’s meeting with DHS officials and military brass! https://t.co/dcXtw73e2j↗
Mar 12
Dustin — $IBRX For anyone who missed today's Citizens Life Sciences Conference, here's the link + key highlights straight from CEO Richard Adcock:
2025 & 2026 will be the most pivotal year…↗
Mar 11
Dustin — $IBRX "Transform the availability of NK cells globally!!"↗
Mar 10
Dustin — $IBRX I hope he drops a major PR announcement tomorrow.↗
Mar 10
Dustin — $IBRX The downtrend is losing steam, and buyers are stepping back in. We're in a transition phase—prime spot for a cup-and-handle to start forming.
Shorts are trapped in this tigh…↗
Mar 9
Dustin — $SLS $IBRX Not just shareholders would benefit…
I am praying every day to win over the cancer because it will save millions of lives around the world! I am sure shorts hate me f…↗
Mar 9
Adam Feuerstein ✡️ — The $RLMD bladder cancer data (phase 2) reported this morning look very good.
Another competitive blow to $IBRX particularly at its bloated valuation.
https://t.co/wYThfwIpG8↗
Mar 9
Dustin — $IBRX My focus is waiting for the FDA to announce if it accepts IBXR's revised sBLA filing for Anktiva and BCG for 2L papillary alone after BCG failure.
IBRX stated in a Jan. 19,…↗
Mar 8
Dustin — $IBRX Saudi approval was around Jan 14 and commercial launch planned within 60 days. So that puts launch around Mar 14. Awaiting great news on launch!
Also you can follow me,…↗
Mar 6
Dustin — $IBRX The FDA risks it becoming widely known that a potential game-changing cancer treatment sat on their desks while thousands more lives were lost. The safety and efficacy data a…↗
Mar 6
Dustin — $IBRX Yep, that's exactly why Dr. Pat dropped that history lesson on last week's earnings call. He straight-up told the FDA regulators (and us retail folks) it's time to move IL-15…↗
Mar 5
Dustin — $IBRX Anktiva is in a demand-constrained launch. Patient demand and hospital adoption for Anktiva is off the charts, and revenue today is only limited primarily by manufacturing sc…↗
Mar 4
Dustin — $IBRX
ImmunityBio price target raised to $12 from $7 at Piper Sandler
Raise your hands who added on that dip…? 🙋♂️ https://t.co/LdYkK8zKlS↗
Mar 4
Dustin — If you found this thread helpful:
you can follow me, I'll be tracking $IBRX all the way.
Thank you.↗
Mar 4
Dustin — $IBRX ImmunityBio Q4 Earnings Call Highlights
1) ImmunityBio said ANKTIVA drove a “transformational” 2025 commercial ramp with net product revenue of $113 million versus $14.1 mil…↗
Mar 4
Dustin — $IBRX more buying opportunity! Max pain for Friday is $9.00, so that might be the strange behavior 🤦♂️ https://t.co/k8LK9xhmuC↗
Mar 3
mon — My current portfolio:
LT:
$IREN
$ONDS
$KRKNF
ST:
$UAMY
$AXTI
$TE
$ALMU
$OUST
$NUAI
$OSS
Researching: $IBRX, $HYFT, $POET, $REAX, $LAES, $SATS, $JOBY, $COPX & $USAR. ✍️↗
Mar 3
Dustin — $IBRX I think everyone should just calm down with the rockets to the moon tomorrow.
I’m really bullish here but we can’t depend on news releases everyday to keep going up. This wil…↗
Mar 3
Dustin — $IBRX really hyping it up today!
Our Dr is on 🔥 tonight! Can’t wait for tomorrow’s call!
Feel free to follow me, I'll be posting updates and covering it in real time.↗
Mar 2
Dustin — $IBRX Hold your shares this is going to become epic…..
I’m not concerned about what happens Monday. Unless a significant PR is dropped. TUESDAY’S call will provide us everything w…↗
Mar 2
Dustin — $IBRX Looks like the general market is shrugging off the doomsday scenario...↗
Mar 2
Dustin — $IBRX Tuesday’s call is the official launch.
The 2025 numbers have been released already. As usual, without fanfare.
What’s brand new is an actual call on Tuesday.
There is ze…↗
Mar 2
Dustin — $IBRX Remember the days of loading up between $1.90 and 2.50? Purchasing a huge number of shares then was bit more dicey, as the chart was diving towards the 52 week lows and threa…↗
Mar 1
Dustin — $IBRX I just re-watched the Cuomo panel from last night, and that woman, Knudsen, was just insufferable as she was seemingly trying to take over as moderator, redirecting the flow…↗
Dustin — $IBRX Something cooking for tomorrow night. He made it to Fox News, the biggest audience by far. 6 PM Brett Baier Fix News 8 PM Cuomo News Nation.
you dont go on national prime…↗
Feb 26
Dustin — $IBRX What I learned today by the price movement and glancing at some of your comments throughout the day is that 99% of you have no clue what you are talking about. "Oh, they are…↗
Feb 25
Dustin — $IBRX
The biggest challenge in oncology today:
many tumors don’t respond to checkpoint therapy at all.
If a platform can create immune activity where none existed:
• it expand…↗
Feb 25
Dustin — $IBRX Trump isn't going to say Immunity Bio but he may talk.about cancer funding and cures. Thats good enough. But even if he doesn't say that, if you watched the presentation, it…↗
Feb 24
Adam Feuerstein ✡️ — Th FDA is absolutely correct, and confirms what I’ve said all along. This $IBRX @DrPatrick “lymphopenia” push means nothing until or unless they come up with real data showing pati…↗
Feb 24
mon — $IBRX +471.78% YTD. 🤯
Really, congrats to everyone who got in early. The stock has been absolutely incredible. https://t.co/yiisBQd3xH↗
Feb 24
Adam Feuerstein ✡️ — $IBRX $12B market cap, on par w $BMRN, just behind $BBIO $NBIX and larger than $JAZZ $MDGL
Your 2026 biotech meme stock...↗
Feb 24
Dustin — $IBRX as great as it would be to have the DOC at SOTU and get a shout out but I don’t think we should get our hopes up. Trump wants to cure cancer as he’s stated but this is way bi…↗
Feb 24
Dustin — $IBRX PSS was at West Point last week… that was not an accident.
I have a feeling the good Doctor will speak at the Nixon conference and then head over for the State of the Union…↗
Feb 24
Dustin — $IBRX Institutional ownership is at all-time highs!!
They now hold 180M+ shares...
Almost as if they know what's coming.
Watching closely!
you can follow me, I'll be tracking $…↗
Feb 20
Adam Feuerstein ✡️ — @oshea9_harry @IdenixH @pdsandiego Nothing you state here changes the regulatory requirements that $IBRX cannot meet.↗
Feb 20
Adam Feuerstein ✡️ — @Rajesh_198911 @IdenixH @Adam1996Indep Then $IBRX should file. It will be rejected.↗
Feb 20
Adam Feuerstein ✡️ — @Adam1996Indep $IBRX needs to demonstrate reversal of lymphopenia leads to a clinical outcome (benefit) for patients.
Epogen treats anemia, but it was approved first in chronic k…↗
Feb 20
Adam Feuerstein ✡️ — Reversal of lymphopenia is not an acceptable endpoint for Anktiva FDA approval. $IBRX could file but if it did, the application would be rejected.↗
Feb 20
Dustin — $IBRX PR TODAY again
The expansion news doesn’t stop. 33 EU countries this week and with the following .:.
Today - partnership deal with two of the Largest Distributors in t…↗
Feb 20
Adam Feuerstein ✡️ — @aakashgupta Aakash - Thank you for framing the bull-bear debate over $IBRX in more realistic terms. You don't quite have the short thesis correct.
Sales growth in 2025 was impr…↗
Feb 18
Adam Feuerstein ✡️ — Look at $IBRX today!
Anktiva was approved in Europe for "in situ" bladder cancer, the same indication already approved in the US.
Today news, not a surprise. The CHMP positive…↗
Feb 18
mon — So many great stocks, so little capital. 🧐
If I were building my own ETF:
$IREN
$ONDS
$CIFR
$NBIS
$WULF
$IBRX
$PL
$ASTS
$RKLB
$NUAI
$POET
$ALMU
$KRKNF
$UAMY
$COPX
$OUST
$TE
$ENPH…↗
Feb 15
Adam Feuerstein ✡️ — “Adam, you’re such a shorty loser. You’re obsessed with $IBRX!” — X accounts that post 24x7 about $IBRX
This is always my favorite.↗
Feb 15
Adam Feuerstein ✡️ — This is not a Saudi-USA Biotech Alliance, it’s a Saudi @DrPatrick $IBRX “you pay we pay” marketing campaign. Anktiva is stalled in the US because he can’t generate the clinical dat…↗
Feb 13
Dustin — $IBRX ...Volume = SWEET...Just hit 5M shs, lots of BIG buys!!↗
Feb 13
Dustin — $IBRX penny flippers selling for 3 percent to make lunch money↗
Feb 12
Adam Feuerstein ✡️ — @pdsandiego @DrPatrick Merck's initial approval in the MSI-H/dmmr pathway was conducted in patients with refractory disease.
It has since conducted RCTs in newly diagnosed patien…↗
Feb 12
Adam Feuerstein ✡️ — It would be highly instructive to read the pembrolizumab paper highlighted by @DrPatrick. Of course, he doesn't expect anyone to do that. This is what it says IN THE FIRST PARAGRAP…↗
Feb 12
Adam Feuerstein ✡️ — @pdsandiego Incorrect. $IBRX has run afoul of the FDA bc it didn't follow the agency's clearly stated guidance for papillary bladder cancer. The FDA didn't move the goalpost, @DrPa…↗
Feb 11
Dustin — $IBRX Everyone, today the stock went from $7.X to $6.57 in 30 minutes. This was a blatant and obvious short attack.
I believe they failed because they could only knock it down 4…↗
Feb 11
Dustin — $IBRX Current free float is 107 million shares, short interest is 135 million shares!
what's really wild is short interest went up after PSS called out the shorts and stock price…↗
Feb 10
Adam Feuerstein ✡️ — @salc7822 @DrPatrick I do. The Saudi strategy is intended to divert attention away from $IBRX regularly failures here and delays in completing clinical trials.↗
Feb 10
Adam Feuerstein ✡️ — @salc7822 @DrPatrick Ah! Clinical trial results that demonstrate a benefit would be helpful. Do you see $IBRX completing any of its studies in the near term?↗
Feb 10
Adam Feuerstein ✡️ — How does $IBRX benefit from the Saudi FDA approval of Anktiva? What say the fanboys/girls of @DrPatrick on this question?
I'm not talking about the stock price, so spare me that…↗
Feb 10
Dustin — $IBRX I will say this again. Stop worrying about the after hours trading. It is literally 12 guys and a toaster...
Like if you agree.↗
Feb 10
Dustin — $IBRX ...Longs, I can't prove this, but I believe the Saudis bought millions of shs during that third week of January. The Saudis view this relationship as good for their people…↗
Feb 9
Adam Feuerstein ✡️ — Finally? @DrPatrick $IBRX needs to freshen up his cell therapy knowledge. This Lilly-Orna deal is the fourth acquisition of an in vivo CAR-T developer by a large drug maker, behind…↗
Adam Feuerstein ✡️ — @Sanctuary_Bio @alc2022 Same idiot touting $IBRX will save the world.↗
Feb 6
Dustin — $IBRX President Trump State of the Union and the CANCER CURE MOONSHOT, on the 24th at 8:45 pm.
Trump will do something at the SOTU address or he never will . Trump is very aware…↗
Feb 5
Dustin — $IBRX On days like this, there is so much garbage on X...from bringing up old lawsuit settlements to predictions of a merger with Musk and Tesla, plus, plus, plus. Nothing has c…↗
Feb 4
Dustin — $IBRX Chart updated
Institutional ownership is at all-time highs!!
They now hold 161M+ shares...
Almost as if they know what's coming.
Watching closely!
you can follow me, I'l…↗
Feb 4
Dustin — $IBRX HOLD ON TO YOUR SHARES. As of right now market makers still pin $6 for support and $7.5 for resistance for February options. If it breaks above$7.5 they have to chase the pr…↗
Feb 4
Dustin — $IBRX PSS does not just tag ppl in posts for the hell of it, there is reasoning behind this, just follow the tea leaves, its all coming together, ELON knows PSS , its not just som…↗
Feb 3
Dustin — $IBRX if pltr trades with a mkt cap of 60 time’s anticipated revenues , right now, Ibrx with 80 billion in revenues ( current anktiva annual capacity) stock would trade at $5000 pe…↗
Feb 3
Dustin — $IBRX if you’re a long term holder of this stock or your relatively new and did your DD you probably know why you bought it. The majority of the population is radically unaware of…↗
Feb 2
Adam Feuerstein ✡️ — @GuywithUmbrella Autologous CAR-Ts: Gilead's Yescarta and Bristol's Breyanzi. Both are approved, with survival benefits, across different lymphoma indications.
Allogeneic (off th…↗
Feb 2
Adam Feuerstein ✡️ — @biotraderusa Reporting n=4 is highly misleading, but that's what $IBRX chose to do.↗
Feb 2
Adam Feuerstein ✡️ — @pdsandiego Correct. Those benchmarks include conditioning, but a $IBRX non-conditioning regimen with suboptimal remission rates will be a non-starter.↗
Feb 2
Adam Feuerstein ✡️ — $IBRX NK cell therapy showing 50% durable CR rate in indolent NHL (and just WM) is suboptimal, lower than competing allogeneic and autologous CAR-Ts.↗
Feb 2
Dustin — $IBRX
I love the positioning “The World Bank of NK Cells..”
The good Dr will make IBRX the global repository….wow… https://t.co/03A316ggEX↗
Feb 2
Dustin — $IBRX With all of the possibilities I don't think we have enough manufacturing capacity. IMO we might need 2 more Dunkirk's pretty quick.
It is my understanding that between Dunki…↗
Feb 1
Dustin — $IBRX In regards to the whole "President Trump and HRH MBS : a shared vision to cure cancer with the BioShield."
I think there is real possibility that Trump and Saudi Wealth f…↗
Feb 1
Dustin — $IBRX this cant be much better news....way to go
Like if you STILL believe $IBRX !
Don't just watch from the sidelines —
follow me😁, I'll be tracking $IBRX all the way. https:…↗
Dustin — $IBRX By including AstraZeneca (AZN) imagery alongside his announcement of the "8-minute bites" (starting tomorrow, Jan 30), Dr. Pat is signaling a massive shift in how ImmunityBio…↗
Jan 30
Adam Feuerstein ✡️ — @IdenixH @bullishbruk Then you should push $IBRX to submit a BLA.↗
Jan 30
Adam Feuerstein ✡️ — Show of hands, how many $IBRX @DrPatrick acolytes on this platform are antisemites? Be honest, most of you basement-dwelling cowards post anonymously, anyway.↗
Jan 30
Adam Feuerstein ✡️ — @IdenixH @bullishbruk Yes. That was nearly one year ago. $IBRX has stopped talking about seeking approval for a lymphopenia indication because simply reversing it is not an FDA-acc…↗
Jan 29
Adam Feuerstein ✡️ — @seahorse_anton @DrPatrick Incorrect. The FDA will decide whether or not to approve $IBRX Anktiva for papillary bladder cancer based on the current data. That is what matters.↗
Jan 29
Adam Feuerstein ✡️ — @aiApotheosis @Jeromepowwpoww @DrPatrick I have not falsified information at any time, anywhere.
I do not invest in individual stocks. I don’t have a short position in $IBRX or a…↗
Jan 29
Adam Feuerstein ✡️ — $IBRX ImmunityBio’s Soon-Shiong mischaracterized talks with FDA over cancer drug, sources say
The company had expressed shock at the agency’s response to its submission
https://t…↗
Jan 29
Adam Feuerstein ✡️ — In this week's Biotech Scorecard newsletter:
$IBRX ImmunityBio and its Chairman Patrick Soon-Shiong @DrPatrick mischaracterized talks with FDA over expanding use of Anktiva, its…↗
Jan 29
Dustin — $IBRX I think we are getting real close to a major PR. All of this talk about US/Saudi partnership and it is moderated by Dr Soon? C'mon this a little obvious. And no money is comi…↗
Jan 28
Dustin — $IBRX Did this stock not just run from $1.98 to almost $8.30 over the past two weeks? Now we have people bitching about it bleeding every day to roughly mid to high 5’s. It’s par…↗
Jan 28
Dustin — $IBRX Based on short-term price targets offered by five analysts, the average price target for ImmunityBio comes to $11.80. The forecasts range from a low of $7.00 to a high of $24…↗
Jan 27
Dustin — $IBRX
Key take away from today's filing, the current terms on the note are 8% over the 3 month SOFR rate (approximately 3.67%) so effectively 11.67% equating to close to 5M mont…↗
Jan 26
Dustin — $IBRX Why the 175M Shorts are Screwed
When your brother says the stock is "diluted," show him why this dilution is actually a Short Trap:
Dr. Pat's 818M Wall: These 168 million s…↗
Adam Feuerstein ✡️ — @hema_Toma @DrPatrick The participants in $IBRX GBM study are not “when all else failed.” They have recurrent disease. TTF is approved in this setting, as is bevacizumab.↗
Jan 24
Adam Feuerstein ✡️ — Yet, @DrPatrick $IBRX fails to mention that with only 6 months of median follow up in these recurrent GBM patients, making any claim about extended survival is nonsense, especially…↗
Jan 24
Wayne Liang — One proper swing can change your life.
Just these past few days, we nailed:
$SATL +50.43%
$IBRX +40.07%
$NUAI +61.93%
$RDW +13.30%
$SIDU +18.41%
$TE +12.11%
Imagine compounding…↗
Jan 24
Dustin — $IBRX I’m not a big “SSR” conspiracy theorist of that really mattering, but with this amount of shorts and possible volume this can generate, if they dropped something crazy on Mon…↗
Jan 23
Adam Feuerstein ✡️ — @Biohazard3737 Meantime, the value of Patrick Soon Shiong's 69% ownership stake in $IBRX has increased by $3.3B YTD.↗
Jan 23
Dustin — $IBRX Someone SOLD 5000 of the March 9 Strike PUTS and took in $1,570,000 Cash and then Bought 5000 of the March 9 Calls for $525,000. If stock closes at 9 the trade nets 1,045,000…↗
Jan 22
mon — Great day so far.
- Bought $NUAI and $IBRX recently.
- Already up more than 50% on both.
- $IREN +4%. $UAMY +6%. $ONDS +3%.
- A stock no one is talking about $LAES +12%.
- Added to…↗
Jan 21
mon — What an incredible day.
- $IREN was down 9% at one point and finished the day down just 1%.
- The new stock I bought yesterday, $NUAI, is up 24%.
- A stock I bought last week,…↗
Jan 21
mon — I’ve been trading fairly actively this month.
I’ve made a lot of trades, made a few mistakes, and got stopped out of a couple of positions I didn’t really want to sell.
At the…↗
Jan 20
mon — The three stocks I've added to my Short-Term portfolio last week:
$IBRX +31.9%
$LPTH +7.9%
$KOPN -4.2%
Currently researching all three stocks.
Watching:
$UMAC 👀↗
Jan 20
mon — $IBRX WOW, now up 31%. 🤯
I'm currently up 50.88%.↗
Jan 20
mon — One of the new stock I bought last week is $IBRX.
Currently up 21.01%.
I'm up 39.53%.
Thanks to @Umbisam and @SaiseiInvesting for putting this on my radar. https://t.co/B1lSt2nZ…↗
Jan 19
Jacob Plieth — @singhlosophy @Sanctuary_Bio $IBRX is becoming the new $NWBO, or is it not quite as bad as that?↗
Jan 19
Adam Feuerstein ✡️ — The $IBRX Quilt-3.092 CAR-NK study also requires patients to undergo lymphodepleting chemotherapy prior to cell therapy infusion.
https://t.co/fPMR7Jhwht↗
Jan 15
Adam Feuerstein ✡️ — $IBRX Anktiva q/q sales growth slowed, cash balance decreased.
How much dilutive cash did the company raise from its adjusted ATM in January? https://t.co/UTKcVOAs4x
Classic: Is…↗
Jan 14
Adam Feuerstein ✡️ — @SweetStocks22 @bullishbruk @DrPatrick @LoriMills4CA42 this anonymous account who posts nonstop about $IBRX has consistently lied about the reasons for my skepticism. This idea tha…↗
Jan 14
Adam Feuerstein ✡️ — @SweetStocks22 @DrPatrick The glioblastoma data (scant) come from single arm combination trials. None of the data prove Anktiva is having any effect at all.
And yes, Anktiva is a…↗
Jan 14
Adam Feuerstein ✡️ — @SweetStocks22 @DrPatrick What does Anktiva "working" mean? Contrary to $IBRX claims, boosting ALC count is not a patient benefit or regulatory outcome recognized by the FDA. The t…↗
Jan 14
Adam Feuerstein ✡️ — The Saudi FDA approved $IBRX Anktiva in lung cancer based on a discontinued randomized study with inconclusive post-hoc data + a non-randomized study with a made-up nonsense respon…↗
Jan 14
Jacob Plieth — @bradloncar @DrPatrick Pat evidently thought he'd get more out of chairing the Saudi summit today. And lo! $IBRX https://t.co/Cu7xCbr3PV↗
Jan 6
Adam Feuerstein ✡️ — $FATE and several other biotechs studied engineered NK cells targeting cancer. The results were nearly universally disappointing. This $IBRX effort isn’t any different.↗
Jan 4
Adam Feuerstein ✡️ — I suggest completing one of the many Anktiva clinical trials. Notable that this seemingly important milestone isn’t mentioned. $IBRX↗
— I wouldn’t rule out the possibility that Anktiva, by raising lymphocyte counts, prolongs cancer survival. Maybe it’s the cancer cure that Soon-Shiong promises. But instead of just…
Adam Feuerstein ✡️ — This week's Biotech Scorecard newsletter:
Piercing the hype around Patrick Soon-Shiong’s ‘Bioshield’ cancer treatment
Clinical trial results presented earlier this week do not s…↗
Sep 7
Adam Feuerstein ✡️ — @drpatrick Dr. Soon-Shiong — Can you please post the WCLC poster on the $IBRX website?↗
Sep 2
Adam Feuerstein ✡️ — @DavidDin @ImmunityBio This $IBRX lung cancer trial is not new. Results were reported last year, in fact at the same lung cancer conference last year. This weekend's presentation i…↗
Sep 1
Adam Feuerstein ✡️ — @WealthWithRG What would an $IBRX FDA label for lymphopenia look like? I’m unaware of a randomized study that ties ALC to improved patient outcomes. All the data I’ve seen is posth…↗
Sep 1
Adam Feuerstein ✡️ — @drpatrick Dr. Soon-Shiong - Has $IBRX published the full data from the Quilt-3.055 NSCLC study? The presentations I've found are incomplete. Where can we find all the baseline dat…↗